Insider Trading Alert - BMR, SEE And ASPS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Aug. 13, 2014, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,704.50 to $121,177,500.00.

Highlighted Stocks Traded by Insiders:

BioMed Realty (BMR) - FREE Research Report

McDevitt Matthew G, who is Executive VP, Real Estate at BioMed Realty, sold 16,000 shares at $22.01 on Aug. 13, 2014. Following this transaction, the Executive VP, Real Estate owned 122,328 shares meaning that the stake was reduced by 11.57% with the 16,000-share transaction.

The shares most recently traded at $22.17, up $0.16, or 0.72% since the insider transaction. Historical insider transactions for BioMed Realty go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 7,000
  • 24-Week # shares sold: 44,771

The average volume for BioMed Realty has been 1.4 million shares per day over the past 30 days. BioMed Realty has a market cap of $4.3 billion and is part of the financial sector and real estate industry. Shares are up 22.57% year-to-date as of the close of trading on Wednesday.

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. The stock currently has a dividend yield of 4.58%. The company has a P/E ratio of 83.9. Currently, there are 7 analysts who rate BioMed Realty a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BMR - FREE

TheStreet Quant Ratings rates BioMed Realty as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth, increase in net income, revenue growth and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full BioMed Realty Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Sealed Air (SEE) - FREE Research Report

Manning Kenneth P, who is Director at Sealed Air, bought 5,000 shares at $33.39 on Aug. 13, 2014. Following this transaction, the Director owned 113,048 shares meaning that the stake was boosted by 4.63% with the 5,000-share transaction.

The shares most recently traded at $34.05, up $0.66, or 1.94% since the insider transaction. Historical insider transactions for Sealed Air go as follows:

  • 4-Week # shares sold: 4,000
  • 12-Week # shares sold: 4,000
  • 24-Week # shares sold: 4,000

The average volume for Sealed Air has been 1.6 million shares per day over the past 30 days. Sealed Air has a market cap of $7.0 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are down 0.94% year-to-date as of the close of trading on Wednesday.

Sealed Air Corporation, through its subsidiaries, provides food safety and security, facility hygiene, and product protection solutions worldwide. The company operates through three segments: Food Care, Diversey Care, and Product Care. The stock currently has a dividend yield of 1.57%. The company has a P/E ratio of 42.0. Currently, there are 4 analysts who rate Sealed Air a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SEE - FREE

TheStreet Quant Ratings rates Sealed Air as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Sealed Air Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Altisource Portfolio Solutions (ASPS) - FREE Research Report

Hynes Mark J., who is President, Technology Services at Altisource Portfolio Solutions, bought 1,000 shares at $87.20 on Aug. 13, 2014. Following this transaction, the President, Technology Services owned 15,460 shares meaning that the stake was boosted by 6.92% with the 1,000-share transaction.

The shares most recently traded at $89.90, up $2.70, or 3% since the insider transaction. Historical insider transactions for Altisource Portfolio Solutions go as follows:

  • 4-Week # shares bought: 2,004
  • 12-Week # shares bought: 2,804
  • 24-Week # shares bought: 2,804

The average volume for Altisource Portfolio Solutions has been 256,400 shares per day over the past 30 days. Altisource Portfolio Solutions has a market cap of $1.9 billion and is part of the services sector and diversified services industry. Shares are down 43.84% year-to-date as of the close of trading on Wednesday.

Altisource Portfolio Solutions S.A. operates as a marketplace and transaction solutions provider for the real estate, mortgage, and consumer debt industries in the United States. The company has a P/E ratio of 13.2. Currently, there is 1 analyst who rates Altisource Portfolio Solutions a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ASPS - FREE

TheStreet Quant Ratings rates Altisource Portfolio Solutions as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, expanding profit margins, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Altisource Portfolio Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Stocks Tumble as Trump Calls Off North Korea Summit

Stocks Tumble as Trump Calls Off North Korea Summit

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Celgene Shares Rise on Plans to Increase Stock Buybacks

Celgene Shares Rise on Plans to Increase Stock Buybacks

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern